Results 321 to 330 of about 315,728 (345)
Some of the next articles are maybe not open access.

Immunogenicity of immunoliposomes

Immunology Letters, 1991
Multilamellar immunoliposomes were prepared from dipalmitoylphosphatidylcholine (DPPC), cholesterol (CH), sphingomyelin (SPH) and biotinylated dipalmitoylphosphatidylethanolamine (PEB) in the molar ratio of 1:1:1:0.1 with surface linked avidin-biotinylated sheep (anti-mouse IgG) IgG (AV-sIgGB) or GK1.5 monoclonal rat (antimouse L3T4 antigen) IgG (AV ...
Nigel C. Phillips, Andrew Emili
openaire   +3 more sources

Immunogens of rotaviruses

Veterinary Microbiology, 1993
Rotaviruses cause gastroenteritis in neonates of many animal species including cattle, swine, horses, dogs, cats, chickens and turkeys. Rotavirions are nonenveloped, are about 75 nm in diameter, have a double capsid, and contain 11 double-stranded RNA segments as their genome.
Young S. Lyoo, Prem S. Paul
openaire   +3 more sources

PLATELETS AS IMMUNOGENS

Vox Sanguinis, 1992
An immune response to human platelet antigens (HPA), as in neonatal alloimmune thrombocytopenia (NAIT) and post-transfusion purpura (PTP), is the exception rather than the rule and evidence is accumulating for the importance of human leucocyte antigen (HLA) class II restriction in this situation.
openaire   +5 more sources

The immunogenicity of biopharmaceuticals

Neurology, 2003
The medical use of proteins has a long history. It started more than one century ago when immune sera of animal origin were introduced for the prevention or treatment of infections, followed by the use of insulin of porcine and bovine origin some decades later.
openaire   +4 more sources

Interchangeability, immunogenicity and biosimilars [PDF]

open access: possibleNature Biotechnology, 2012
For authorized biosimilars to achieve full acceptance in the marketplace, it is crucial that they are considered to be therapeutically equivalent and interchangeable with the brand reference product.
Hans C. Ebbers   +3 more
openaire   +4 more sources

Chemotherapy Immunogenicity

1980
A number of studies have demonstrated that a moderate immune reaction may augment the response to chemotherapy. Two approaches are examined in the current report: (a) chemoimmunotherapy with viable L1210 cells that were antigenically altered by treatment with DTIC (L1210/DTCI), and (b) chemotherapy plus treatment with lymphocytes from mice immunized ...
A, Goldin, A, Nicolin, E, Bonmassar
openaire   +2 more sources

Immunogenicity of allograft components

Cellular Immunology, 1981
Abstract We describe an assay for in vivo quantitation of the “immunogenicity” of isolated cell populations. The assay is based on the observation that if an AgB-incompatible recipient rat is primed with donor strain spleen cells 72 hr prior to transplantation, heart allograft survival is reduced from 6.2 to 3.0 days.
Elaine Parthenais   +3 more
openaire   +3 more sources

Immunogene Therapy

2012
Antigenic differences between normal and malignant cells of the cancer patient form the rationale for clinical immunotherapeutic strategies. Because the antigenic phenotype of neoplastic cells varies widely among different cells within the same malignant cell-population, immunization with a vaccine that stimulates immunity to the broad array of tumor ...
Terry, Lichtor, Roberta P, Glick
openaire   +2 more sources

Immunogens of Pasteurella

Veterinary Microbiology, 1993
The family Pasteurellaceae Pohl contains Gram-negative, facultatively anaerobic and fermentative bacteria of the genera Pasteurella, Haemophilus, and Actinobacillus. Approximately 20 different species of the genus Pasteurella have been identified using phenotypic and genetic analyses. Of these species, P. multocida and P.
openaire   +3 more sources

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

The Pediatric Infectious Disease Journal, 2000
Objective. To determine the efficacy, safety and immunogenicity of the heptavalent CRM197 pneumococcal conjugate vaccine against invasive disease caused by vaccine serotypes and to determine the effectiveness of this vaccine against clinical episodes of ...
S. Black   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy